Luis Miguel
Antón Aparicio
![Foto de Luis Miguel](/img/nophoto.png)
![Foto de Complexo Hospitalario Universitario da Coruña](/img/noimage_org.png)
Complexo Hospitalario Universitario da Coruña
La Coruña, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (33)
2024
-
The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis
Molecular Oncology, Vol. 18, Núm. 5, pp. 1093-1122
2018
-
Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies
Expert Opinion on Drug Safety, Vol. 17, Núm. 6, pp. 573-579
2014
-
Cabazitaxel for metastatic castration-resistant prostate cancer: Safety data from the Spanish expanded access program
Expert Opinion on Drug Safety, Vol. 13, Núm. 9, pp. 1165-1173
-
Cancer stem cells in genitourinary cancer
Stem Cells in Cancer: Should We Believe or Not? (Springer Netherlands), pp. 149-165
2013
-
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor
Clinical and Translational Oncology, Vol. 15, Núm. 6, pp. 425-433
-
Erratum: Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor (Clinical and Translational Oncology DOI: 10.1007/s12094-012-0985-x)
Clinical and Translational Oncology
2012
-
Cytokine and endocrine signaling in prostate cancer
Medical Oncology, Vol. 29, Núm. 3, pp. 1956-1963
2011
-
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients
Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 16, pp. 2433-2439
2010
-
Renal cell carcinoma: Complete pathological response in a patient with gastric metastasis of renal cell carcinoma
Anti-Cancer Drugs, Vol. 21, Núm. SUPPL.1
2009
-
MicroRNAs as circulating tumor cells biomarkers in gastrointestinal cancer
EJC SUPPLEMENTS
-
The role of COX-2 in prostate carcinoma: Therapeutical implications
Handbook of Prostate Cancer Cell Research: Growth, Signalling, and Survival (Nova Science Publishers, Inc.), pp. 363-388
2008
-
Diagnosis value of EGFR gene expression for early diagnosis in oral leukoplakias
EJC SUPPLEMENTS
-
Effectiveness of COX2 inhibitor treatment in patients with dysplastic oral leukoplakia
EJC SUPPLEMENTS
-
Origin of renal cell carcinomas
Clinical and Translational Oncology, Vol. 10, Núm. 11, pp. 697-712
-
Utility of p53 gene expression for early diagnosis in oral leukoplakias
EJC SUPPLEMENTS
2007
-
Choroid plexus carcinoma: A rare condition and its therapeutic management
Clinical and Translational Oncology, Vol. 9, Núm. 6, pp. 401-403
-
Cyclooxygenase-2 (COX-2): A molecular target in prostate cancer
Clinical and Translational Oncology, Vol. 9, Núm. 11, pp. 694-702
-
Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: A lung cancer Galician group phase II study
Cancer Chemotherapy and Pharmacology, Vol. 60, Núm. 5, pp. 725-732
-
Non-seminomatous germ-cell tumour associated with acute megakaryoblastic leukaemia
Clinical and Translational Oncology, Vol. 9, Núm. 5, pp. 329-331
-
Prostate cancer and Hedgehog signalling pathway
Clinical and Translational Oncology, Vol. 9, Núm. 7, pp. 420-428